Headache Relief Tablet, Film Coated
NDC Package 46122-690-78
Package Information
Headache Relief (acetaminophen, aspirin, caffeine) tablets is do not take more than directeddrink a full glass of water with each doseadults and children 12 years and over: take 2 caplets every 6 hours. This formulation utilizes a tablet, film coated delivery system. Marketed by Amerisource Bergen, this product is identified by NDC 46122-690 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 308297 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet
- RxCUI: 308297 - APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
- Central Nervous System Stimulation - [PE] (Physiologic Effect)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Methylxanthine - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Xanthines - [CS]
Regulatory & Marketing
Hierarchy Structure
- 46122 - Amerisource Bergen
- 46122-690 - Headache Relief
- 46122-690-78 - 1 BOTTLE, PLASTIC in 1 CARTON / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 46122-690 - Headache Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 46122-690-78 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 100 tablet, film coated in 1 bottle, plastic of Headache Relief, a human over the counter drug labeled by Amerisource Bergen. This tablet, film coated is formulated for oral use and contains acetaminophen; aspirin; caffeine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amerisource Bergen on March 11, 2021. The current certification is valid through December 31, 2027.
How is this Amerisource Bergen product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 46122069078. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.